Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Participant characteristics at baseline (n = 14)

From: Outcomes of a pilot feasibility study of comprehensive geriatric assessment for younger frail patients with severe mental illness

Variable

N

%

Demographic and clinical characteristics

  

Male

12

85.7

White/Caucasian

13

92.8

Australian born

13

92.8

ATSI descent

0

-

Unemployed

13

92.8

Primary diagnosis

  

Schizophrenia

1

7.1

Paranoid schizophrenia

7

50.0

Schizoaffective disorder

4

28.6

Bipolar affective disorder

2

14.3

Prescribed medications

  

Clozapine (mean dosage; mg)a

8 (403.1)

57.1

Polypharmacy (≥ 5)a

13

92.8

High polypharmacy (≥ 9)a

11

78.6

Physical characteristics

  

Current smoking

4

28.6

Metabolic health

  

Normal weightb

1

5.9

Pre-obesity (overweight)b

5

29.4

Obesityb

11

64.7

 

M

SD

BMI

34.6

8.4

Waist circumference (cm)

120.4

15.0

Frailty Index at screening

0.35

0.08

Clinical assessments

  

Psychosis symptoms (PANSS total scale)

66.6

13.1

Physical component (SF-36)

55.6

26.1

Mental component (SF-36)

62.4

20.4

Global functioning (GAF total score)

47.8

6.1

Quality of life (AQOL-8D total score)

64.8

14.8

Physical activity (min; SIMPAQ)c

184.6

217.9

Sedentary time (min; SIMPAQ)

588.6

256.3

Fruit & vegetable intake (portions; FACET)

4.4

2.4

Sleep (PSQI global score)

6.8

4.0

  1. ATSI, Aboriginal and Torres Strait Islander; BMI, Body Mass Index; SD, standard deviation; SF-36, Medical Outcomes Scale Short Form-36; PANSS, Positive and Negative Syndrome Scale; GAF, Global Assessment of Functioning; MVPA, moderate-to-vigorous physical activity; PSQI, Pittsburgh Sleep Quality Index; SIMPAQ, Simple Physical Activity Questionnaire; FACET, Five-a-day Community Evaluation Tool; AQoL-8D, Assessment of Quality of Life
  2. a Other prescribed medications were: aripiprazole (2 participants), allopurinol (1 participant), amisulpride (1 participant), allopurinol (1 participant), brexpiprazole (1 participant), and sertraline (1 participant). Polypharmacy was defined as concurrent use of 525 and of 9 or more regular medications [26].
  3. b BMI was classified into groups based on World Health Organization classification of nutritional status.37 Among the participants with Obesity, 4 had a BMI that corresponded with ‘Obesity class I’ (23.5%) category, 3 with BMI of ‘Obesity class II’ (17.6%), and 4 whose BMI corresponded with ‘Obesity class III’ category
  4. c Physical activity was assessed using moderate-to-vigorous physical activity domain of the SIMPAQ, which includes time spent walking and time spent exercising